Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice

CRISPR/Cas9 technology has been used for genome engineering in vivo. Here, the authors use a transfection technique to deliver multiple guide RNAs to the pancreas of adult mice, allowing genetic screening and chromosome engineering in pancreatic cancer.

Bibliographic Details
Main Authors: Roman Maresch, Sebastian Mueller, Christian Veltkamp, Rupert Öllinger, Mathias Friedrich, Irina Heid, Katja Steiger, Julia Weber, Thomas Engleitner, Maxim Barenboim, Sabine Klein, Sandra Louzada, Ruby Banerjee, Alexander Strong, Teresa Stauber, Nina Gross, Ulf Geumann, Sebastian Lange, Marc Ringelhan, Ignacio Varela, Kristian Unger, Fengtang Yang, Roland M. Schmid, George S. Vassiliou, Rickmer Braren, Günter Schneider, Mathias Heikenwalder, Allan Bradley, Dieter Saur, Roland Rad
Format: Article
Language:English
Published: Nature Publishing Group 2016-02-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/ncomms10770
id doaj-8d54419326794a6ba55ff4332e373a04
record_format Article
spelling doaj-8d54419326794a6ba55ff4332e373a042021-05-11T10:57:00ZengNature Publishing GroupNature Communications2041-17232016-02-017111310.1038/ncomms10770Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in miceRoman Maresch0Sebastian Mueller1Christian Veltkamp2Rupert Öllinger3Mathias Friedrich4Irina Heid5Katja Steiger6Julia Weber7Thomas Engleitner8Maxim Barenboim9Sabine Klein10Sandra Louzada11Ruby Banerjee12Alexander Strong13Teresa Stauber14Nina Gross15Ulf Geumann16Sebastian Lange17Marc Ringelhan18Ignacio Varela19Kristian Unger20Fengtang Yang21Roland M. Schmid22George S. Vassiliou23Rickmer Braren24Günter Schneider25Mathias Heikenwalder26Allan Bradley27Dieter Saur28Roland Rad29Department of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenWellcome Trust Sanger Institute, Wellcome Trust Genome CampusInstitute of Radiology, Klinikum rechts der Isar, Technischen Universität MünchenDepartment of Pathology, Klinikum rechts der Isar, Technische Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenWellcome Trust Sanger Institute, Wellcome Trust Genome CampusWellcome Trust Sanger Institute, Wellcome Trust Genome CampusWellcome Trust Sanger Institute, Wellcome Trust Genome CampusDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenInstituto de Biomedicina y Biotecnología de CantabriaHelmholtz Zentrum München, Research Unit Radiation CytogeneticsWellcome Trust Sanger Institute, Wellcome Trust Genome CampusDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenWellcome Trust Sanger Institute, Wellcome Trust Genome CampusInstitute of Radiology, Klinikum rechts der Isar, Technischen Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenInstitute of Virology, Technische Universität München/Helmholtz Zentrum MünchenWellcome Trust Sanger Institute, Wellcome Trust Genome CampusDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenDepartment of Medicine II, Klinikum rechts der Isar, Technische Universität MünchenCRISPR/Cas9 technology has been used for genome engineering in vivo. Here, the authors use a transfection technique to deliver multiple guide RNAs to the pancreas of adult mice, allowing genetic screening and chromosome engineering in pancreatic cancer.https://doi.org/10.1038/ncomms10770
collection DOAJ
language English
format Article
sources DOAJ
author Roman Maresch
Sebastian Mueller
Christian Veltkamp
Rupert Öllinger
Mathias Friedrich
Irina Heid
Katja Steiger
Julia Weber
Thomas Engleitner
Maxim Barenboim
Sabine Klein
Sandra Louzada
Ruby Banerjee
Alexander Strong
Teresa Stauber
Nina Gross
Ulf Geumann
Sebastian Lange
Marc Ringelhan
Ignacio Varela
Kristian Unger
Fengtang Yang
Roland M. Schmid
George S. Vassiliou
Rickmer Braren
Günter Schneider
Mathias Heikenwalder
Allan Bradley
Dieter Saur
Roland Rad
spellingShingle Roman Maresch
Sebastian Mueller
Christian Veltkamp
Rupert Öllinger
Mathias Friedrich
Irina Heid
Katja Steiger
Julia Weber
Thomas Engleitner
Maxim Barenboim
Sabine Klein
Sandra Louzada
Ruby Banerjee
Alexander Strong
Teresa Stauber
Nina Gross
Ulf Geumann
Sebastian Lange
Marc Ringelhan
Ignacio Varela
Kristian Unger
Fengtang Yang
Roland M. Schmid
George S. Vassiliou
Rickmer Braren
Günter Schneider
Mathias Heikenwalder
Allan Bradley
Dieter Saur
Roland Rad
Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
Nature Communications
author_facet Roman Maresch
Sebastian Mueller
Christian Veltkamp
Rupert Öllinger
Mathias Friedrich
Irina Heid
Katja Steiger
Julia Weber
Thomas Engleitner
Maxim Barenboim
Sabine Klein
Sandra Louzada
Ruby Banerjee
Alexander Strong
Teresa Stauber
Nina Gross
Ulf Geumann
Sebastian Lange
Marc Ringelhan
Ignacio Varela
Kristian Unger
Fengtang Yang
Roland M. Schmid
George S. Vassiliou
Rickmer Braren
Günter Schneider
Mathias Heikenwalder
Allan Bradley
Dieter Saur
Roland Rad
author_sort Roman Maresch
title Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
title_short Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
title_full Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
title_fullStr Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
title_full_unstemmed Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
title_sort multiplexed pancreatic genome engineering and cancer induction by transfection-based crispr/cas9 delivery in mice
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2016-02-01
description CRISPR/Cas9 technology has been used for genome engineering in vivo. Here, the authors use a transfection technique to deliver multiple guide RNAs to the pancreas of adult mice, allowing genetic screening and chromosome engineering in pancreatic cancer.
url https://doi.org/10.1038/ncomms10770
work_keys_str_mv AT romanmaresch multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT sebastianmueller multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT christianveltkamp multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT rupertollinger multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT mathiasfriedrich multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT irinaheid multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT katjasteiger multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT juliaweber multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT thomasengleitner multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT maximbarenboim multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT sabineklein multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT sandralouzada multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT rubybanerjee multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT alexanderstrong multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT teresastauber multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT ninagross multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT ulfgeumann multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT sebastianlange multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT marcringelhan multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT ignaciovarela multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT kristianunger multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT fengtangyang multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT rolandmschmid multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT georgesvassiliou multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT rickmerbraren multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT gunterschneider multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT mathiasheikenwalder multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT allanbradley multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT dietersaur multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
AT rolandrad multiplexedpancreaticgenomeengineeringandcancerinductionbytransfectionbasedcrisprcas9deliveryinmice
_version_ 1721447307096883200